OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Klebsiella pneumoniae: adaptive immune landscapes and vaccine horizons
Paeton L. Wantuch, David A. Rosen
Trends in Immunology (2023) Vol. 44, Iss. 10, pp. 826-844
Open Access | Times Cited: 22

Showing 22 citing articles:

Vaccine value profile for Klebsiella pneumoniae
Ziyaad Dangor, Nicole M. Benson, James A. Berkley, et al.
Vaccine (2024) Vol. 42, Iss. 19, pp. S125-S141
Open Access | Times Cited: 16

Revisiting therapeutic options against Resistant Klebsiella Pneumoniae infection: phage therapy is key
Jiabao Xing, Rong-jia Han, Jinxin Zhao, et al.
Microbiological Research (2025), pp. 128083-128083
Closed Access | Times Cited: 1

Mechanisms of Antibiotic Resistance and Developments in Therapeutic Strategies to Combat Klebsiella pneumoniae Infection
Yanping Li, Suresh Kumar, Lihu Zhang
Infection and Drug Resistance (2024) Vol. Volume 17, pp. 1107-1119
Open Access | Times Cited: 14

Heptavalent O-Antigen Bioconjugate Vaccine Exhibiting Differential Functional Antibody Responses Against Diverse Klebsiella pneumoniae Isolates
Paeton L. Wantuch, Cory J. Knoot, Lloyd S. Robinson, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 3, pp. 578-589
Closed Access | Times Cited: 12

Hypervirulent and carbapenem-resistant Klebsiella pneumoniae: A global public health threat
Ting-yu Lei, Bin-bin Liao, Liang-Rui Yang, et al.
Microbiological Research (2024) Vol. 288, pp. 127839-127839
Closed Access | Times Cited: 7

Vaccines and monoclonal antibodies to prevent healthcare-associated bacterial infections
Léo Sauvat, Paul O. Verhoeven, Julie Gagnaire, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 3
Closed Access | Times Cited: 4

Zeolitic Imidazole Framework‐8 Nanoparticles as an Alternative to Freund's Adjuvant for Klebsiella pneumoniae Recombinant Protein Vaccine
Gaowei Hu, Chunli Hong, Yingjie Miao, et al.
Biotechnology and Bioengineering (2025)
Closed Access

O-antigen polysaccharides in Klebsiella pneumoniae : structures and molecular basis for antigenic diversity
Chris Whitfield, Steven D. Kelly, Thad B. Stanton, et al.
Microbiology and Molecular Biology Reviews (2025)
Closed Access

Insights into the roles of macrophages in Klebsiella pneumoniae infections: a comprehensive review
Yangguang Li, Xuanheng Li, Wenqi Wu, et al.
Cellular & Molecular Biology Letters (2025) Vol. 30, Iss. 1
Open Access

A rational designed multi-epitope vaccine elicited robust protective efficacy against Klebsiella pneumoniae lung infection
Jingwen Liao, Xiaoli Zhang, Xi Zeng, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116611-116611
Open Access | Times Cited: 3

Anti-capsule human monoclonal antibodies protect against hypervirulent and pandrug-resistantKlebsiella pneumoniae
Emanuele Roscioli, V. Fonseca, Soraya S. Bosch, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3

Risk Factors for Multidrug Resistance in Patients Infected with Carbapenem-Resistant Klebsiella pneumoniae: A Nomogram
Yaning Gao, Liang Chen, Zhengjun Wen, et al.
Infection and Drug Resistance (2024) Vol. Volume 17, pp. 4833-4841
Open Access | Times Cited: 2

Human vaccine candidates for infections caused by Klebsiella pneumoniae: A systematic review
Hajar Motamed, F. Yari, Etrat Javadirad, et al.
Health Science Reports (2024) Vol. 7, Iss. 9
Open Access | Times Cited: 1

Klebsiella pneumoniae bioconjugate vaccine functional durability in mice
Paeton L. Wantuch, Cory J. Knoot, Emily C. Marino, et al.
Vaccine (2024) Vol. 43, pp. 126536-126536
Open Access | Times Cited: 1

A heptavalent O-antigen bioconjugate vaccine exhibits differential functional antibody responses against diverseKlebsiella pneumoniaeisolates
Paeton L. Wantuch, Cory J. Knoot, Lloyd S. Robinson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3

Prioritizing Endemic Pathogens for Vaccine Research and Development by Capturing Regional and Country Stakeholder Values
Mateusz Hasso-Agopsowicz, Angela Hwang, Maria-Graciela Hollm-Delgado, et al.
(2024)
Closed Access

Lung infection with classical Klebsiella pneumoniae strains establishes robust macrophage-dependent protection against heterologous reinfection
Joseph J. Mackel, Casey L.G. Mick, Emily Guo, et al.
Microbes and Infection (2024) Vol. 26, Iss. 8, pp. 105369-105369
Open Access

Phosphate‐containing glycolipids: a review on synthesis and bioactivity
Luís Pinheiro, Marisa Freitas, Paula S. Branco
ChemMedChem (2024)
Closed Access

Current innovations in mRNA vaccines for targeting multidrug-resistant ESKAPE pathogens
Saber İmani, S. Lv, Hongbo Qian, et al.
Biotechnology Advances (2024), pp. 108492-108492
Open Access

New Strategies Needed in the Fight against Antimicrobial Resistance
Farah Azouzi
Journal of Biomedical Research & Environmental Sciences (2023) Vol. 4, Iss. 11, pp. 1611-1613
Open Access

Page 1

Scroll to top